Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Radiation disasters and children.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline.

AAP Policies are reviewed every 3 years by the authoring body, at which time a recommendation is made that the policy be retired, revised, or reaffirmed without change. Until the Board of Directors approves a revision or reaffirmation, or retires a statement, the current policy remains in effect.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Recommendations for Pediatricians

  1. Pediatricians should increase their knowledge about emergency medical aspects of radiation exposure.
  2. Pediatricians should become familiar with local preparedness and evacuation protocols and work with public health agencies on their development.
  3. Pediatricians should assist local schools and child care facilities in developing protocols to reunite children with their parents in the event of a disaster.
  4. All children at risk should receive potassium iodide (KI) before exposure, if possible, or immediately afterward. This will require that KI be available in homes located within 10 miles of a nuclear power plant. Child care facilities and schools within 10 miles of a nuclear power plant should plan to stockpile the agent. It may be prudent to consider stockpiling KI within a larger radius because of more distant windborne fallout, as occurred after Chernobyl; this will be determined by local and national public health authorities. For KI dosage and administration information refer to table 2 in the original guideline document.
  5. The risks and benefits of using KI should be discussed with parents. KI is available without a prescription, and families should be cautioned against using the medication before consulting with authorities.
  6. Because radioiodines pass into breast milk, pediatricians should caution lactating mothers not to breastfeed their infants after the release of radioiodines, unless no alternative is available. The restriction is temporary, until public health authorities declare it safe to go back to breastfeeding. Public health authorities will also advise about the safe consumption of produce and milk after a radiation disaster.
  7. The pediatrician should recognize and respond to the psychosocial consequences of disasters in children (National Council on Radiation Protection and Measurements, 2001; American Academy of pediatrics, 1999; American Academy of Pediatrics, 2000).

Recommendations for Government

  1. Pediatricians should be included in all aspects of planning for a radiation disaster. Disaster planning exercises should include pediatric casualties and victims with mock psychologic injuries.
  2. Future sites for nuclear power facility construction should be selected to minimize the risk to populations. For existing power plants in populated regions, an accelerated timeline for decommissioning should be considered.
  3. Guidelines for the population radius within which to recommend KI stockpiling should be developed; distribution plans should also be created.
  4. The Food and Drug Administration (FDA) should facilitate the development of a pediatric preparation of KI.
  5. Plans should be developed for rapid communication with the public about evacuation versus sheltering, the safety of breast milk, and local food consumption.
  6. Government planners should make mental health a high priority in the response plan for a radiation incident.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

REFERENCES SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is not specifically stated for each recommendation.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: Guideline was not adapted from another source.

DATE RELEASED

2003 Jun

GUIDELINE DEVELOPER(S)

American Academy of Pediatrics - Medical Specialty Society

SOURCE(S) OF FUNDING

American Academy of Pediatrics

GUIDELINE COMMITTEE

Committee on Environmental Health

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Members of the Committee on Environmental Health, 2002-2003: *Sophie J. Balk, MD (Chairperson); Dana Best, MD, MPH; Christine L. Johnson, MD; Janice J. Kim, MD, PhD, MPH; Lynnette J. Mazur, MD, MPH; David W. Reynolds, MD; James R. Roberts, MD, MPH; *Michael W. Shannon, MD, MPH; William B. Weil, Jr, MD

Liaisons: Robert W. Amler, MD (Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry); Elizabeth Blackburn, RN (US Environmental Protection Agency); Martha Linet, MD (National Cancer Institute); *Robert W. Miller, MD, DrPH (National Cancer Institute); Walter Rogan, MD (National Institute of Environmental Health Sciences)

Staff: Paul Spire

*Lead authors

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

AAP Policies are reviewed every 3 years by the authoring body, at which time a recommendation is made that the policy be retired, revised, or reaffirmed without change. Until the Board of Directors approves a revision or reaffirmation, or retires a statement, the current policy remains in effect.

GUIDELINE AVAILABILITY

Electronic copies: Available from the American Academy of Pediatrics (AAP) Policy Web site.

Print copies: Available from American Academy of Pediatrics, 141 Northwest Point Blvd., P.O. Box 927, Elk Grove Village, IL 60009-0927.

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on December 11, 2003. The information was verified by the guideline developer on February 2, 2004.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. Please contact the Permissions Editor, American Academy of Pediatrics (AAP), 141 Northwest Point Blvd, Elk Grove Village, IL 60007.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo